Showing results (181-190 of 193) with videos related to
Sort By:
Pageof 20
The British Journal of Dermatology|January 10, 2025
Functional genotype classification groups distinguish disease severity in recessive dystrophic epidermolysis bullosaPirunthan Pathmarajah, Edward Eid, Jaron Nazaroff, et al.JAMA Dermatology|December 27, 2018
Assessment of the Timing of Milestone Clinical Events in Patients With Epidermolysis Bullosa From North AmericaJames A Feinstein, Purevsuren Jambal, Kathleen Peoples, et al.Pediatric Dermatology|April 23, 2020
Systemic immunosuppressive therapy for inflammatory skin diseases in children: Expert consensus-based guidance for clinical decision-making during the COVID-19 pandemicSean D Reynolds, Anubhav N Mathur, Yvonne E Chiu, et al.Pediatric Dermatology|April 17, 2020
Management of infantile hemangiomas during the COVID pandemicIlona J Frieden, Katherine B Püttgen, Beth A Drolet, et al.The Journal of Investigative Dermatology|November 28, 2017
Analyzing the Genetic Spectrum of Vascular Anomalies with Overgrowth via Cancer GenomicsDawn H Siegel, Catherine E Cottrell, Jenna L Streicher, et al.Journal of the American Academy of Dermatology|December 1, 2023
Risk factors and outcomes of melanoma in children and adolescents: A retrospective multicenter studyElena B Hawryluk, Danna Moustafa, Kelly K Barry, et al.The Journal of Investigative Dermatology|October 26, 2012
Copy number variation analysis in 98 individuals with PHACE syndromeDawn H Siegel, Joseph T C Shieh, Eun-Kyung Kwon, et al.Journal of the American Academy of Dermatology|October 11, 2021
A retrospective analysis of diagnostic testing in a large North American cohort of patients with epidermolysis bullosaGregory Scott Phillips, Amy Huang, Bret D Augsburger, et al.Journal of the American Academy of Dermatology|August 24, 2024
Approach to Mycosis Fungoides in children: Consensus-based recommendationsAlex Zvulunov, Holly Neale, Jonah Stern, et al.The New England Journal of Medicine|June 5, 2009
An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonistIvona Aksentijevich, Seth L Masters, Polly J Ferguson, et al.Pageof 20